How much funding has 23andMe raised?

23andMe has raised $382.5M in total funding, most recently a Series B round.

Who are 23andMe's investors?

23andMe's investors include Sequoia Capital, Richard Branson, Yuri Milner, Anne Wojcicki, NewView Capital, Euclidean Capital.

Where is 23andMe headquartered?

23andMe is headquartered in San Francisco Bay Area, California, United States.

What industry is 23andMe in?

23andMe operates in Biotech, DNA Testing, Healthcare.

How many employees does 23andMe have?

23andMe has 501-1000 employees.

23andMe

IPO

DNA testing for ancestry, health, and you

Public · San Francisco Bay Area, United States · Founded 2006 · $382.5M raised

Biotech

DNA Testing

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 501–1000
Founded: 2006
Business Model: B2C
Website: 23andme.com

Total Funding: $382.5M
Last Round: $82.5M Series BDec 2020
Rounds: 3
Type: Public

About

23andMe is an American personal genomics and biotechnology company based in South San Francisco, California. Founded in 2006, the company provides direct-to-consumer DNA testing services that help individuals understand their ancestry composition across 4,500+ geographic regions, health predispositions, carrier status, pharmacogenetics, and wellness traits. The company operates one of the world's largest consumer genomics databases and enables customers to connect with DNA relatives. 23andMe also conducts large-scale genetic research with consenting customers to advance scientific understanding of complex diseases.

Summary

23andMe is a Biotech company based in San Francisco Bay Area, United States, founded in 2006. It has raised $382.5M in total across 3 rounds, most recently a $82.5M Series B round in Dec 2020. Investors include Sequoia Capital, Richard Branson and Yuri Milner.

LinkedIn X (Twitter)